These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 16442287

  • 1. How cyclodextrins can mask their toxic effect on the blood-brain barrier.
    Binkowski-Machut C, Hapiot F, Martin P, Cecchelli R, Monflier E.
    Bioorg Med Chem Lett; 2006 Apr 01; 16(7):1784-7. PubMed ID: 16442287
    [Abstract] [Full Text] [Related]

  • 2. Behavior of alpha-, beta-, and gamma-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier.
    Monnaert V, Tilloy S, Bricout H, Fenart L, Cecchelli R, Monflier E.
    J Pharmacol Exp Ther; 2004 Aug 01; 310(2):745-51. PubMed ID: 15082751
    [Abstract] [Full Text] [Related]

  • 3. Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier.
    Monnaert V, Betbeder D, Fenart L, Bricout H, Lenfant AM, Landry C, Cecchelli R, Monflier E, Tilloy S.
    J Pharmacol Exp Ther; 2004 Dec 01; 311(3):1115-20. PubMed ID: 15280439
    [Abstract] [Full Text] [Related]

  • 4. Cyclodextrins promote protein aggregation posing risks for therapeutic applications.
    Wang MS, Boddapati S, Sierks MR.
    Biochem Biophys Res Commun; 2009 Aug 28; 386(3):526-31. PubMed ID: 19540204
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the potential toxicity of unmodified and modified cyclodextrins on murine blood-brain barrier endothelial cells.
    Shityakov S, Salmas RE, Salvador E, Roewer N, Broscheit J, Förster C.
    J Toxicol Sci; 2016 Apr 28; 41(2):175-84. PubMed ID: 26961601
    [Abstract] [Full Text] [Related]

  • 6. Methylated beta-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier.
    Tilloy S, Monnaert V, Fenart L, Bricout H, Cecchelli R, Monflier E.
    Bioorg Med Chem Lett; 2006 Apr 15; 16(8):2154-7. PubMed ID: 16464592
    [Abstract] [Full Text] [Related]

  • 7. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
    Silwedel C, Förster C.
    J Neuroimmunol; 2006 Oct 15; 179(1-2):37-45. PubMed ID: 16884785
    [Abstract] [Full Text] [Related]

  • 8. New strategy for alerting central nervous system toxicity: Integration of blood-brain barrier toxicity and permeability in neurotoxicity assessment.
    Hallier-Vanuxeem D, Prieto P, Culot M, Diallo H, Landry C, Tähti H, Cecchelli R.
    Toxicol In Vitro; 2009 Apr 15; 23(3):447-53. PubMed ID: 19135142
    [Abstract] [Full Text] [Related]

  • 9. An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening.
    Culot M, Lundquist S, Vanuxeem D, Nion S, Landry C, Delplace Y, Dehouck MP, Berezowski V, Fenart L, Cecchelli R.
    Toxicol In Vitro; 2008 Apr 15; 22(3):799-811. PubMed ID: 18280105
    [Abstract] [Full Text] [Related]

  • 10. In vitro toxicity and permeation of cyclodextrins in Calu-3 cells.
    Matilainen L, Toropainen T, Vihola H, Hirvonen J, Järvinen T, Jarho P, Järvinen K.
    J Control Release; 2008 Feb 18; 126(1):10-6. PubMed ID: 18160169
    [Abstract] [Full Text] [Related]

  • 11. [Effect of 1, 2-dichloroethane on blood brain barrier].
    Zhang QL, Wang LP, Guo XL, Niu Q.
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Apr 18; 24(4):239-42. PubMed ID: 16701041
    [Abstract] [Full Text] [Related]

  • 12. n-3 Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier.
    Pifferi F, Jouin M, Alessandri JM, Haedke U, Roux F, Perrière N, Denis I, Lavialle M, Guesnet P.
    Prostaglandins Leukot Essent Fatty Acids; 2007 Apr 18; 77(5-6):279-86. PubMed ID: 18042368
    [Abstract] [Full Text] [Related]

  • 13. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
    Zhang Y, Li CS, Ye Y, Johnson K, Poe J, Johnson S, Bobrowski W, Garrido R, Madhu C.
    Drug Metab Dispos; 2006 Nov 18; 34(11):1935-43. PubMed ID: 16896068
    [Abstract] [Full Text] [Related]

  • 14. MK801 blocks hypoxic blood-brain-barrier disruption and leukocyte adhesion.
    Kuhlmann CR, Zehendner CM, Gerigk M, Closhen D, Bender B, Friedl P, Luhmann HJ.
    Neurosci Lett; 2009 Jan 16; 449(3):168-72. PubMed ID: 18996441
    [Abstract] [Full Text] [Related]

  • 15. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
    Perrière N, Yousif S, Cazaubon S, Chaverot N, Bourasset F, Cisternino S, Declèves X, Hori S, Terasaki T, Deli M, Scherrmann JM, Temsamani J, Roux F, Couraud PO.
    Brain Res; 2007 May 30; 1150():1-13. PubMed ID: 17434463
    [Abstract] [Full Text] [Related]

  • 16. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
    Cucullo L, Hossain M, Rapp E, Manders T, Marchi N, Janigro D.
    Epilepsia; 2007 Mar 30; 48(3):505-16. PubMed ID: 17326793
    [Abstract] [Full Text] [Related]

  • 17. Study on the supramolecular systems of 5-(2-hydroxy phenyl)-10,15,20-tris (4-methoxy phenyl) porphyrin with cyclodextrins.
    Kong LH, Guo YJ, Li XX, Pan JH.
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Mar 30; 66(3):594-8. PubMed ID: 16859961
    [Abstract] [Full Text] [Related]

  • 18. [Cytotoxic examinations of various cyclodextrin derivatives on Caco-2 cells].
    Kiss T, Fenyvesi F, Kovácsné BI, Fehér P, Leposáné KR, Váradi J, Szente L, Fenyvesi E, Iványi R, Vecsernyés M.
    Acta Pharm Hung; 2007 Mar 30; 77(2):150-4. PubMed ID: 17933275
    [Abstract] [Full Text] [Related]

  • 19. Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins.
    Nonaka N, Farr SA, Kageyama H, Shioda S, Banks WA.
    J Pharmacol Exp Ther; 2008 May 30; 325(2):513-9. PubMed ID: 18270319
    [Abstract] [Full Text] [Related]

  • 20. Fluvastatin prevents glutamate-induced blood-brain-barrier disruption in vitro.
    Kuhlmann CR, Gerigk M, Bender B, Closhen D, Lessmann V, Luhmann HJ.
    Life Sci; 2008 Jun 20; 82(25-26):1281-7. PubMed ID: 18534629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.